Welcome to AstraZeneca United States

We push the boundaries of science to deliver life-changing medicines

AZ&You Blog
 

Conversations on Severe Asthma: Realities from the Patient & Advocacy Community

National Kidney Month – Speaking with Your Doctor about CKD

Meet our 2021 Power of Us Award Winners

Portraits of Lung Cancer

Nina Parker on Breaking the Cycle of Asthma

Latest News from AstraZeneca US
 

PT027, a novel fixed-dose combination of albuterol and budesonide, used as an as-needed rescue medicine, significantly reduced the risk of a severe exacerbation compared to albuterol by 27% in patients with asthma

ENHERTU® (fam-trastuzumab deruxtecan-nxki) approved in the US for patients with HER2-positive metastatic breast cancer treated with a prior anti-HER2-based regimen

FARXIGA met primary endpoint in DELIVER Phase III trial, reducing risk of cardiovascular death or worsening heart failure in patients with preserved ejection fraction

ULTOMIRIS® (ravulizumab-cwvz) met primary endpoint in CHAMPION-NMOSD Phase III trial in adults with neuromyelitis optica spectrum disorder

Imfinzi plus chemotherapy granted Priority Review in the US for patients with locally advanced or metastatic biliary tract cancer based on TOPAZ-1 Phase III trial

ULTOMIRIS® (ravulizumab-cwvz) approved in the US for adults with generalized myasthenia gravis

Follow AstraZeneca on Twitter and Facebook

Pascal Soriot calls for global cooperation in the fight against COVID-19 and climate change

COVID-19 Information Hub

BioPharmaceuticals

We want to transform healthcare, change the lives of billions of people for the better and address some of the biggest healthcare challenges facing humankind. Our ambition is to stop the progress of these often degenerative, debilitating, and life-threatening conditions, achieve remission, and one day cure them.

Learn more

Oncology: Start with One

At AstraZeneca, we are leading a revolution in oncology to redefine cancer care for the millions of Americans living with cancer. It’s a lofty ambition. But we know that as with every great journey, the road always starts with one—one indication that can change the course of disease for a patient, one person living with cancer that benefits from our support services, one access barrier that we can help to overcome, one system to transform in partnership with the community—and then another, building from there until success is achieved. Click below to read more about this next chapter.

Learn more